Recent process of using nanoparticles in the T cell-based immunometabolic therapy
Abstract: Immunotherapy is currently the main treatment for malignant tumors by activating immune cell. Metabolic reprogramming in tumor microenvironment can greatly affect the function of immune cell, and T cell is the main anti-tumor effector cell. Therefore, the T cell-based immunometabolic therapy can improve clinical efficacy. In T cell-based immunometabolic therapy, regular agents in conventional forms are difficult to achieve the intended efficacy due to poor tumor permeability and low cellular uptake. Nanoparticle-based strategy can serve as the optimal targeted drug delivery system due to co-encapsulation of multiple therapeutic agents and stable loading. Here, we intend to summarize examples of nanoparticles in the T cell-based immunometabolic therapy, and provide a comprehensive and helpful review by covering notable and vital applications of nanotechnology-based strategies for T cell-based immunometabolic therapy.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Recent process of using nanoparticles in the T cell-based immunometabolic therapy ; volume:13 ; number:1 ; year:2024 ; extent:12
Nanotechnology reviews ; 13, Heft 1 (2024) (gesamt 12)
- Urheber
-
Chen, Bingxin
Li, Yangyang
Wang, Hui
- DOI
-
10.1515/ntrev-2024-0072
- URN
-
urn:nbn:de:101:1-2409241605327.204775639333
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chen, Bingxin
- Li, Yangyang
- Wang, Hui